Outlook Therapeutics, Inc.

8-K Other events Jul 24, 2026 8-K Director or officer change Jul 24, 2026 8-K Amended charter or bylaws; Shareholder vote results Jul 16, 2026 8-K Delisting notice or listing-rule failure Jun 26, 2026 8-K Other events Jun 16, 2026 8-K Other events Jun 1, 2026 8-K Other events May 29, 2026 8-K Other events May 28, 2026 8-K Other events May 26, 2026 8-K Results of operations (earnings release) May 18, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release) May 13, 2026 8-K Unregistered sale of equity; Other events Apr 23, 2026 8-K Other events Apr 21, 2026 8-K Other events Apr 7, 2026 8-K Other events Mar 25, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Other events Mar 16, 2026 8-K Director or officer change Mar 11, 2026 8-K Shareholder vote results Mar 10, 2026 8-K Other events Mar 5, 2026 8-K Delisting notice or listing-rule failure Feb 18, 2026 10-Q Quarter ended 2025-12-31 Feb 17, 2026 8-K Results of operations (earnings release) Feb 17, 2026 8-K Other events Feb 11, 2026 8-K Other events Jan 2, 2026 10-K Fiscal year ended 2025-09-30 Dec 19, 2025 8-K Results of operations (earnings release) Dec 19, 2025 8-K Other events Nov 13, 2025 8-K Other events Nov 3, 2025 8-K Other events Sep 29, 2025 8-K Director or officer change Sep 5, 2025 8-K Other events Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Director or officer change Jul 1, 2025 8-K Other events Jun 2, 2025 8-K Other events May 23, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Director or officer change Apr 11, 2025